Clinical Epigenetics is a highly regarded, open-access journal dedicated to advancing the understanding of epigenetic mechanisms in human health and disease. The journal serves as a platform for researchers and clinicians to share their findings on the role of epigenetics in various clinical areas, including cancer, cardiovascular disease, neurodevelopmental disorders, and autoimmune diseases. Clinical Epigenetics emphasizes translational research, bridging the gap between basic science discoveries and clinical applications.
The journal's scope encompasses a wide range of topics, such as DNA methylation, histone modifications, non-coding RNAs, and chromatin remodeling. It features studies that investigate the epigenetic basis of disease, explore the potential of epigenetic biomarkers for diagnosis and prognosis, and develop novel epigenetic therapies. Indexed in prominent databases, including PubMed Central and Scopus.
With a commitment to open science and knowledge dissemination, Clinical Epigenetics plays a vital role in accelerating the translation of epigenetic discoveries into improved patient care. Researchers are encourage to submit novel clinical and research manuscripts that help the journal to improve the accessibility of health for human and prevent epigenetic disorders. It supports future studies with the open-access status, making the world more accessible to science.